This large observational study of patients with T2DM demonstrated that the initiation of once daily insulin detemir in patients already receiving OHA therapy was effective in improving glycaemic control, and was associated with a low incidence of hypoglycaemia and an overall mean reduction in weight across the entire cohort. This evidence concerns the gene INS and type 2 diabetes mellitus.